Henry Schein Stock

Henry Schein FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Henry Schein (HSIC) as of Aug 14, 2026 is 143.97 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 169.49 % — a change of -15.06% (lower).

FCF Conversion

143.97 %

YoY

-15.06%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Henry Schein is 2026 143.97 % . FCF Conversion Rate (FCF/EBITDA) of Henry Schein was 2025 169.49 % . It decreases by -15.06% lower compared to the previous year.
Access this data via the Eulerpool API

Henry Schein Stock analysis

What does Henry Schein do? Henry Schein Inc is a global provider of medical products and services for the healthcare industry based in Melville, New York. It was founded in 1932 by Henry Schein and has a long history of providing high-quality products and services for the healthcare industry. The company specializes in four core areas: medical products, services, medical software, and veterinary products. In the medical products area, Henry Schein distributes a wide range of medical products and equipment, including dental and orthodontic products, surgical instruments and supplies, medical laboratory equipment and supplies, and furnishings for practices. The company strives to offer its customers the best selection of medical products at a competitive price. Henry Schein also offers services aimed at making the work of healthcare providers easier. For example, the company provides services such as practice management software, online pharmacies, insurance, and billing services to optimize the operation of a medical or veterinary practice. Another important area of the company is medical software. Henry Schein offers an extensive range of software solutions for medical and veterinary practices, as well as hospitals and other medical facilities. The software facilitates tasks such as electronic medical records, appointment scheduling, and financial management, enabling practices and hospitals to operate more efficiently. Henry Schein has also specialized in the field of veterinary medicine, offering a wide range of products and services for veterinarians and animal clinics. The company distributes veterinary instruments, laboratory equipment, surgical instruments, and veterinary medications, and also provides services such as practice management software and veterinary billing. The company aims to provide its customers with a comprehensive range of products and services in a variety of areas. Henry Schein has established itself as an industry leader and is valued for its high quality and excellent customer service. Henry Schein is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Henry Schein stock

FCF Conversion Rate (FCF/EBITDA) of Henry Schein is 143.97 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Henry Schein changed from 169.49 % to 143.97 %, representing a -15.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Henry Schein since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Henry Schein with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Henry Schein

All Key Metrics — Henry Schein